Followers | 4 |
Posts | 293 |
Boards Moderated | 0 |
Alias Born | 02/02/2015 |
Wednesday, October 19, 2016 5:04:35 PM
NaNose Technology:
The Company anticipates receiving requisite IRB regulatory approval in order to commence clinical studies in Surrey, BC, Canada this month. The study has been designed to determine if the NaNose technology can identify differences in the breath signatures of patients with bacterial infections versus patients with viral infections. The ability to differentiate between bacterial versus viral infections at the Point of Care is anticipated to greatly assist physicians with treatment recommendations which could significantly and positively impact the excessive prescribing and resulting overuse of antibiotic-based treatments
.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM